A historical perspective on ACE2 in the COVID-19 era

被引:37
作者
Bhalla, Vivek [1 ,2 ,3 ]
Blish, Catherine A. [3 ,4 ,5 ]
South, Andrew M. [6 ,7 ,8 ]
机构
[1] Stanford Univ, Sch Med, Stanford Hypertens Ctr, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Div Nephrol, Stanford, CA 94305 USA
[3] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA
[4] Stanford Univ, Sch Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA
[5] Chan Zuckerberg Biohub, San Francisco, CA USA
[6] Wake Forest Sch Med, Brenner Childrens Hosp, Dept Pediat, Sect Nephrol, Winston Salem, NC 27101 USA
[7] Wake Forest Sch Med, Dept Surg Hypertens & Vasc Res, Winston Salem, NC 27101 USA
[8] Wake Forest Sch Med, Dept Epidemiol & Prevent, Div Publ Hlth Sci, Winston Salem, NC 27101 USA
关键词
ANGIOTENSIN-CONVERTING ENZYME; AMINO ACID COMPOSITION; RECEPTOR; INHIBITORS; CORONAVIRUS; EXPRESSION; IDENTIFICATION; ANTAGONIST; CAPTOPRIL; BLOCKADE;
D O I
10.1038/s41371-020-00459-3
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
收藏
页码:935 / 939
页数:5
相关论文
共 41 条
[1]   ANTIHYPERTENSIVE ACTIONS OF ANGIOTENSIN-(1-7) IN SPONTANEOUSLY HYPERTENSIVE RATS [J].
BENTER, IF ;
FERRARIO, CM ;
MORRIS, M ;
DIZ, DI .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1995, 269 (01) :H313-H319
[2]   SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF A NOVEL SERIES OF NONPEPTIDE ANGIOTENSIN-II RECEPTOR-BINDING INHIBITORS SPECIFIC FOR THE AT2 SUBTYPE [J].
BLANKLEY, CJ ;
HODGES, JC ;
KLUTCHKO, SR ;
HIMMELSBACH, RJ ;
CHUCHOLOWSKI, A ;
CONNOLLY, CJ ;
NEERGAARD, SJ ;
VANNIEUWENHZE, MS ;
SEBASTIAN, A ;
QUIN, J ;
ESSENBURG, AD ;
COHEN, DM .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (11) :3248-3260
[3]   Hypertension Hot Potato - Anatomy of the Angiotensin-Receptor Blocker Recalls [J].
Byrd, J. Brian ;
Chertow, Glenn M. ;
Bhalla, Vivek .
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (17) :1589-1591
[4]   CARDIOVASCULAR EFFECTS OF ANGIOTENSIN-(1-7) INJECTED INTO THE DORSAL MEDULLA OF RATS [J].
CAMPAGNOLESANTOS, MJ ;
DIZ, DI ;
SANTOS, RAS ;
KHOSLA, MC ;
BROSNIHAN, KB ;
FERRARIO, CM .
AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 257 (01) :H324-H329
[5]  
CHAPPELL MC, 1989, J BIOL CHEM, V264, P16518
[6]   Renin-Angiotensin-Aldosterone Inhibitors and Susceptibility to and Severity of COVID-19 [J].
Curfman, Gregory .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (02) :177-178
[7]   HISTORY OF THE DESIGN OF CAPTOPRIL AND RELATED INHIBITORS OF ANGIOTENSIN CONVERTING ENZYME [J].
CUSHMAN, DW ;
ONDETTI, MA .
HYPERTENSION, 1991, 17 (04) :589-592
[8]   A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9 [J].
Donoghue, M ;
Hsieh, F ;
Baronas, E ;
Godbout, K ;
Gosselin, M ;
Stagliano, N ;
Donovan, M ;
Woolf, B ;
Robison, K ;
Jeyaseelan, R ;
Breitbart, RE ;
Acton, S .
CIRCULATION RESEARCH, 2000, 87 (05) :E1-E9
[9]   Identification of a novel coronavirus in patients with severe acute respiratory syndrome [J].
Drosten, C ;
Günther, S ;
Preiser, W ;
van der Werf, S ;
Brodt, HR ;
Becker, S ;
Rabenau, H ;
Panning, M ;
Kolesnikova, L ;
Fouchier, RAM ;
Berger, A ;
Burguière, AM ;
Cinatl, J ;
Eickmann, M ;
Escriou, N ;
Grywna, K ;
Kramme, S ;
Manuguerra, JC ;
Müller, S ;
Rickerts, V ;
Stürmer, M ;
Vieth, S ;
Klenk, HD ;
Osterhaus, ADME ;
Schmitz, H ;
Doerr, HW .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (20) :1967-1976
[10]   THE DISCOVERY OF DUP-753, A POTENT, ORALLY ACTIVE NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONIST [J].
DUNCIA, JV ;
CARINI, DJ ;
CHIU, AT ;
JOHNSON, AL ;
PRICE, WA ;
WONG, PC ;
WEXLER, RR ;
TIMMERMANS, PBMWM .
MEDICINAL RESEARCH REVIEWS, 1992, 12 (02) :149-191